gefitinib has been researched along with anisomycin in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (anisomycin) | Trials (anisomycin) | Recent Studies (post-2010) (anisomycin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,357 | 0 | 319 |
| Protein | Taxonomy | gefitinib (IC50) | anisomycin (IC50) |
|---|---|---|---|
| Glucose transporter | Leishmania mexicana | 0.225 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.326 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.321 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
1 other study(ies) available for gefitinib and anisomycin
| Article | Year |
|---|---|
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |